THE PREVENT TRIAL
Stopping Lymphedema Starts with PREVENT - Final 3-Year Primary Endpoint Results Published

Specialty

Medical Specialty Oncology

Oncology

Medical Specialty Cardiology

Cardiology

Medical Specialty Rehabilitation & Therapy

Rehab & Therapy

Medical Specialty Research

Research

What More Information?

ImpediMed’s use of BIS has been studied extensively for lymphedema, heart failure and body composition in a wide variety of disease states and for veterinary research applications.

Contact Us